CompletedNCT01909050
Immune Response in Celiac Disease on In-vitro Gluten Challenge
Studying Refractory celiac disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beth Israel Deaconess Medical Center
- Principal Investigator
- Daniel A Leffler, MD, MSBeth Israel Deaconess Medical Center
- Enrollment
- 42 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2013 – 2018
Study locations (1)
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01909050 on ClinicalTrials.gov